Archit Organosys Ltd vs Arvee Laboratories India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 21, 2026

Key Highlights

The Latest Trading Price of Archit Organosys Ltd is ₹ 37.73 as of 20 Mar 15:30 . The P/E Ratio of Archit Organosys Ltd is 10.9 as of March 2023 .The P/E Ratio of Arvee Laboratories (India) Ltd is 0 as of March 2023 . The Market Cap of Archit Organosys Ltd is ₹ 123.92 crore as of March 2023 .The Market Cap of Arvee Laboratories (India) Ltd is ₹ 0 crore as of March 2023 . The revenue of Archit Organosys Ltd for the Dec '25 is ₹ 39.3 crore as compare to the Sep '25 revenue of ₹ 34.32 crore. This represent the growth of 14.51% The revenue of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 9.92 crore as compare to the Sep '25 revenue of ₹ 3.68 crore. This represent the growth of 169.57% The ebitda of Archit Organosys Ltd for the Dec '25 is ₹ 5.58 crore as compare to the Sep '25 ebitda of ₹ 4.16 crore. This represent the growth of 34.13% The ebitda of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 1.76 crore as compare to the Sep '25 ebitda of ₹ 0.36 crore. This represent the growth of 388.89% The net profit of Archit Organosys Ltd changed from ₹ 1.01 crore to ₹ 2.43 crore over 7 quarters. This represents a CAGR of 65.15% The net profit of Arvee Laboratories (India) Ltd changed from ₹ 0.94 crore to ₹ 1.83 crore over 7 quarters. This represents a CAGR of 46.33% The Dividend Payout of Archit Organosys Ltd changed from 14.99 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Arvee Laboratories (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Archit Organosys Ltd

Archit Organosys Limited was originally incorporated on 04th August 1993 as 'Shri Chlochem Limited'.
The Company got the name changed to Archit Organosys Limited from Shri Chlochem Limited effective from 19th May, 2012.
The Company is mainly engaged in the business of manufacturing and trading of various chemical products. Major customers of the Company include several large Indian and International companies who are engaged in the Agrochemical Manufacturing Sector, Pharmaceuticals Manufacturing Sector and Cosmetics Manufacturing Sector.
Company has developed various product like MCA, SMCA, CAC and TCAC. Company is selling their products across Pan India as well as USA, Europe, Latin America, Other Asian Countries and South Africa.
These products are used mainly in pharmaceutical Intermediates like Ibuprofen, Diclofenac, Aceclofenac, Oil field chemicals used for Oil Drilling mainly In CMC manufacturing, Agriculture field product majorly 2,4 D-Acid and many others, surfactants and cosmetic products as well as day to day personal use products, also used in Pigment.

About Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat.
Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017.
Presently, the Company is engaged in manufacturing of specialized chemicals. Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association.
Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started construction of its first plant for Thiophene Derivatives in 2013.

FAQs for the comparison of Archit Organosys Ltd and Arvee Laboratories (India) Ltd

Which company has a larger market capitalization, Archit Organosys Ltd or Arvee Laboratories (India) Ltd?

Market cap of Archit Organosys Ltd is 77 Cr while Market cap of Arvee Laboratories (India) Ltd is 161 Cr

What are the key factors driving the stock performance of Archit Organosys Ltd and Arvee Laboratories (India) Ltd?

The stock performance of Archit Organosys Ltd and Arvee Laboratories (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Archit Organosys Ltd and Arvee Laboratories (India) Ltd?

As of March 21, 2026, the Archit Organosys Ltd stock price is INR ₹37.73. On the other hand, Arvee Laboratories (India) Ltd stock price is INR ₹146.16.

How do dividend payouts of Archit Organosys Ltd and Arvee Laboratories (India) Ltd compare?

To compare the dividend payouts of Archit Organosys Ltd and Arvee Laboratories (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.